CIK 0001531177
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800625749
- Phone
- +1 415-889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Fountain Tamara Director | Grant or award | +15,094 | 0 | ||
| 2023-06-08 | Encrantz Staffan Director | Grant or award | +11,940 | 11,940 | ||
| 2023-06-08 | Encrantz Staffan Director | Grant or award | +15,094 | 11,940 | ||
| 2023-06-08 | Larsen-Becker Brenda Jane Director | Grant or award | +15,094 | 3,679 | ||
| 2023-05-09 | Bauerlein Alison See Remarks | Grant or award | +103,000 | 0 | ||
| 2023-05-09 | Bauerlein Alison See Remarks | Grant or award · Stock Option (Right to Buy) | +71,800 | 71,800 | ||
| 2023-03-16 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award | +45,100 | 1,808 | ||
| 2023-03-16 | HAYDEN JEREMY B. Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +57,700 | 57,700 | ||
| 2023-03-16 | Badawi Paul President and CEO | Grant or award | +176,600 | 5,278,481 | ||
| 2023-03-16 | Badawi Paul President and CEO | Grant or award · Stock Option (Right to Buy) | +225,700 | 225,700 | ||
| 2023-03-16 | Park Sam Boong Chief Operating Officer | Grant or award | +54,100 | 51,424 | ||
| 2023-03-16 | Park Sam Boong Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +69,100 | 69,100 | ||
| 2023-03-16 | Badawi David Chief Technology Officer | Grant or award | +39,100 | 1,485,790 | ||
| 2023-03-16 | Badawi David Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-03-16 | Rodberg James See Remarks | Grant or award | +20,600 | 699 | ||
| 2023-03-16 | Rodberg James See Remarks | Grant or award · Stock Option (Right to Buy) | +14,400 | 14,400 | ||
| 2023-03-15 | Larsen-Becker Brenda Jane Director | Grant or award | +17,923 | 5,974 | ||
| 2023-03-15 | Larsen-Becker Brenda Jane Director | Shares withheld for taxes | −2,295 | $9.08 | $21K | 3,679 |
| 2023-01-08 | Fountain Tamara Director | Grant or award | +17,977 | 0 | ||
| 2023-01-04 | Selnick Jesse Chief Financial Officer | Shares withheld for taxes | −2,891 | $12.38 | $36K | 403,359 |
Page 11 of 16 · 302 trades